Integra Lifesciences (IART)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2007 | 06-2007 | 03-2007 | 12-2006 | 09-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 129,498 | 120,838 | 29,329 | 22,697 | 24,322 |
| Receivables | 92,313 | 95,267 | 85,884 | 85,018 | 76,715 |
| Inventories | 126,371 | 114,089 | 95,591 | 94,387 | 93,773 |
| Income taxes - deferred | 13,562 | 13,011 | 9,555 | 10,010 | 11,337 |
| TOTAL | $380,359 | $352,983 | $229,800 | $221,761 | $219,499 |
| Non-Current Assets | |||||
| PPE Net | 55,262 | 50,632 | 43,702 | 42,559 | 40,659 |
| Intangibles | 360,454 | 358,282 | 341,186 | 342,130 | 336,597 |
| Other Non-Current Assets | 14,002 | 14,593 | 8,386 | 7,168 | 7,705 |
| TOTAL | $429,718 | $423,507 | $393,274 | $391,857 | $384,961 |
| Total Assets | $810,077 | $776,490 | $623,074 | $613,618 | $604,460 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 119,962 | 119,964 | 120,000 | 119,542 | 115,205 |
| Accounts payable and accrued liabilities | 26,928 | 25,827 | 19,255 | 20,329 | 16,255 |
| Accrued Expenses | N/A | 32,371 | 27,778 | 29,827 | 32,010 |
| TOTAL | $188,185 | $181,025 | $273,744 | $274,017 | $255,456 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | N/A | 4,889 |
| Deferred Revenues | 2,786 | 2,863 | 3,401 | 4,319 | 4,986 |
| Other Non-Current Liabilities | 344,667 | 344,541 | 14,478 | 12,083 | 5,540 |
| TOTAL | $371,495 | $371,951 | $43,784 | $43,439 | $43,523 |
| Total Liabilities | $559,680 | $552,976 | $317,528 | $317,456 | $298,979 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 52,726 | 52,510 | 54,970 | 54,655 | 55,543 |
| Common Shares | 322 | 320 | 318 | 315 | 312 |
| Retained earnings | 92,768 | 83,094 | 73,752 | 66,336 | 56,205 |
| Other shareholders' equity | 20,763 | 12,373 | 9,704 | 8,234 | 3,549 |
| TOTAL | $250,397 | $223,514 | $305,546 | $296,162 | $305,481 |
| Total Liabilities And Equity | $810,077 | $776,490 | $623,074 | $613,618 | $604,460 |